title: Programmed haploidentical hematopoietic stem cell infusion combined with systemic chemotherapy improves the outcomes of patients with refractory or relapsed lymphoma.
authors.affiliation: Department of Hematology, the Second Artillery General Hospital , Beijing , China.
authors.forename: Hong-Xia
authors.initials: HX
authors.lastname: Zhao
authors.forename: Wan-Jun
authors.initials: WJ
authors.lastname: Sun
authors.forename: Jie
authors.initials: J
authors.lastname: Li
authors.forename: Hai-Lan
authors.initials: HL
authors.lastname: Hu
authors.forename: Hui-Sheng
authors.initials: HS
authors.lastname: Ai
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D008223:Lymphoma / Q000473:pathology* / Q000628:therapy*; D012008:Recurrence; D035781:Siblings; D014184:Transplantation, Homologous; D016896:Treatment Outcome